How PM IQShield can benefit your children

Being a parent, you are the one who determines if your children get a good start in life. You want your children to experience the best that life has to offer. How you help them to develop, and to achieve, can be the basis upon which it all starts.

Like any parent, the health of your children is always your first priority. The basis of good health is nutrition. While the way your child is raised forms the foundation for the rest of their lives, nutrition is the foundation for your child’s health and development.

What if you are having difficulty in getting your children to eat properly? Or, even if they eat well but you still want to make sure they have all the nutrition essentials. PM IQShield may be the answer.

Along with a healthy diet and lifestyle, IQShield is formulated to provide the nutritional support your children require to maintain their health and optimise their development. This includes supporting cell health and cell production, and assisting the development of neural health, with benefits to eye, and immune health. IQShield can assist your child’s performance, improving their behaviour, and reducing the risk of behavioural problems. IQShield improves physical and immune system development, reducing the risk of allergies and infections, while building upon their constitution, and laying a solid foundation for continued health and development throughout their life.

Your Child’s Health
It is easy for your children to become deficient in DHA and EPA fatty acids, and the essential nutrients iodine and zinc. Add to these nutrients colostrum and vitamins B1, B2, and B12, these nutrients assist neural development, providing benefits to your child’s mental and physical abilities.

Central and Peripheral Nervous System Development
IQShield is a source of high grade tuna oil (natural) containing omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Improved physical and mental development has been reported in children whose diets included DHA supplementation. Benefits include better attention, concentration, learning, cognition and memory, with a lower risk of attention deficit (hyperactivity) disorder (ADD/ADHD), anxiety, stress and impulsive behaviour. While DHA makes up 60% of brain tissue, EPA assists in regulating mood, with children at a lower risk of experiencing depression.

The tuna oil in IQShield is processed and tested based on US Pharmacopoeia standards. The tuna included in this product is fished from the pristine South Pacific waters ensuring a clean source, and is comparatively rich in DHA, with a 5:1 ratio of DHA to EPA similar to that present in nutrient-rich human breast milk.

The iodine contained in IQShield is required for the production of thyroid hormones, which are necessary for normal brain development and cognition. Iodine supplementation for instance, in the form of iodised oil has been found to significantly improve cognition in school children.

Zinc modulates communication between neurones (neurotransmission) within the brain. Zinc does this through its action on ion channels. Zinc is highly concentrated within the brain, improving spatial learning, memory, attention ability, and visual reaction time.

Children are dependent on their dietary intake to fulfill their thiamin requirements. Because there is very little thiamin stored within the body, one can become deficient in a matter of days. Severe chronic thiamin deficiency can result in potentially serious complications involving the brain and nervous system. This is illustrated in the link link between thiamin deficiency and a form of dementia known as Wernicke-Korsakoff syndrome.

If your child’s dietary intake is insufficient, riboflavin supplementation may be required for the maintenance of adequate cognitive function. Supplementation with B-vitamins including riboflavin has been reported to improve depression and cognitive function.

A deficiency of vitamin B12 can lead to abnormal neurologic and psychiatric symptoms. These symptoms may include uncontrollable movements, muscle weakness, incontinence, hypotension (low blood pressure), vision problems, dementia, psychoses, and mood disturbances. These symptoms have been reported to occur when vitamin B12 levels are just slightly lower than normal. This has been illustrated in some patients misdiagnosed with Alzheimer's disease. Vitamin B12 deficiency often causes disorientation and confusion, mimicking some of the symptoms associated with Alzheimer's disease. For this reason, vitamin B12 is included in PM IQShield.

Cell Production and Health
PM IQShield provides benefits for cell health (function and production) as well as cell membrane integrity. Zinc is incorporated into the make up of all cells, being essential for maintaining cell health and integrity. Zinc contains protective properties, reduces cell damage that may be brought on by oxidative stress.

Eye Development and Sight
The eye is composed of a network of nerves for vision processing. As with the brain and other neural tissue, DHA is in high demand during eye development and is essential for eye health. As with neural tissue, DHA is incorporated into eye cell tissue, becoming a component in eye cell structure.

Iodine, while primarily essential for metabolism, has been of benefit to eye health. Iodine, in the form of povidone-iodine solution, has been used in the management of childhood bacterial conjunctivitis. Povidone-iodine ophthalmic solution appears to have broad-spectrum activity against bacteria.

There is also evidence that zinc assists in the maintenance of eye health. Zinc offers protection to the main optic nerve, as well as providing antioxidant properties. Thiamin and riboflavin has been found to benefit eye health. High dietary thiamin for instance, has been found to decrease the risk of some eye conditions that occur later in life such as cataracts, while low riboflavin levels may be a risk factor for developing cataracts later in life.

These ingredients assist eye sight development, providing long term benefits in eye health, increasing resistance to infections and reducing the risk of symptoms associated with many eye conditions.

Metabolism
Iodine deficiency is one of the causes of goiter (hypertrophy of the thyroid gland as it tries to make more thyroid hormone in the absence of iodine). Physically, goiter appears as an abnormal enlargement of the thyroid gland in the neck.

Although goiter due to low iodine intake is rare in developed countries, it may occur in regions with endemic low iodine levels. To avoid iodine deficiency in some countries, table salt is enriched with iodine ("iodised" salt), and iodine is added to cattle feed and used as a dough conditioner.

In patients experiencing tiredness and fatigue, vitamin B12 appears to improve their general well-being and happiness.

Immune Health
Children are often more susceptible to pathogens, and more likely to be affected by viral and bacterial infections. The combination of DHA, EPA, colostrum, iodine and zinc assists immune system development and maintenance as well as providing protection against free radicals.

Fish oil has also been found to provide benefits to immune health while reducing allergy based symptoms. The nature of this protection is not quite clear however these benefits appear to be linked to DHA and EPA fatty acids.

The colostrum (bovine) contained in PM IQShield is made up of whey proteins, oligosaccharides, immunoglobulins, growth factors (e.g. IGF-1, IGF-2, TGFbeta and EGF, prolactin, insulin), amino acids, lactoferrin and other beneficial proteins and enzymes. Colostrum is a major source of secretory IgA (immunoglobulin A), a naturally occurring antibody.

Apart from providing immune system support, there has been some suggestion that bovine colostrum may be effective for improving gastrointestinal health. Colostrum has been found to assist in alleviating diarrhoea. Colostrum inhibits the adhesion or activity of Clostridium difficile and Escherichia coli bacteria to intestinal cells. Bovine colostrum is high in rotavirus antibody has also been noted to prevent rotavirus diarrhea.

On top of its benefits in maintaining cell health and integrity, zinc, in combination with iodine, and vitamins B1, B2, and B12, assists the immune system in providing protection against free-radicals, reducing and preventing cell damage.

Other benefits
Although research is still ongoing, there is evidence that the fish oil content in PM IQShield is beneficial for long term bone and joint health. Research has shown that fish oil helps reduce the risk of symptoms associated with different forms of arthritis and other joint complaints. Fish oil also benefits cardiovascular health, inhibiting clotting factors and improving blood circulation. Fish oil also provides benefits for skin care. DHA and EPA fatty acids increase hydration and skin cell protection. Research has shown that tuna oil improves the condition of damaged and inflamed skin.

Apart from Zinc’s cell health and antioxidant properties, higher levels of zinc is associated with benefits in heart and vascular conditions, diabetes, blood fats, and glucose intolerance.

The beneficial effects of PM IQShield can be seen in the health and development of your child. The use of PM IQShield along with a healthy diet and lifestyle can assist your children, providing long lasting benefits well into their adult life.

References

1. Kidd, PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev. 2007 Sep;12(3):207-27.
2. Helland IB, et al. Maternal Supplementation With Very-Long-Chain n-3 Fatty Acids During Pregnancy and Lactation Augments Children’s IQ at 4 Years of Age. Pediatrics 2003;111;e39-e44
3. Richardson, AJ, Montgomery P. The Oxford-Durham Study: A randomised, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics (2005) 115:1360-1366
4. Nemets H et al. Omega-3 treatment of childhood depression: A controlled, double-blind pilot study. American Journal of Psychiatry (2006) 163:1098-1100.
5. Amminger GP et al. Omega-3 fatty acids supplementation in children with autism: A double-blind, randomized, placebo-controlled pilot study. Biological Psychiatry (2007) 61:551-553.
6. Seddon JM, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol. 2001 Aug;119(8):1191-9.
7. Cho E et al. Prospective study of dietary fat and the risk of age-related macular degeneration. American Journal of Clinical Nutrition (2001) 73(2):209-218
8. Peat JK et al. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. Journal of Allergy and Clinical Immunology (2004) 114:807-813.
9. Schiano V et al. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: Effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr. 2008 Jan 29
10. Tziomalos K, Athyros VG, Mikhailidis DP. Fish oils and vascular disease prevention: an update. Curr Med Chem. 2007;14(24):2622-8.
11. Surette ME. The science behind dietary omega-3 fatty acids CMAJ. 2008 Jan 15;178(2):177-80.
12. Thapa, B. R. Health factors in colostrum. Indian J Pediatr 2005;72(7):579-581 
13. Sarker, S. A., Casswall, T. H., Mahalanabis, D., Alam, N. H., Albert, M. J., Brussow, H., Fuchs, G. J., and Hammerstrom, L. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr.Infect.Dis.J. 1998;17(12):1149-1154. 
14. Rump, J. A., Arndt, R., Arnold, A., Bendick, C., Dichtelmuller, H., Franke, M., Helm, E. B., Jager, H., Kampmann, B., and Kolb, P. Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clin.Investig. 1992;70(7):588-594. 
15. Mitra, A. K., Mahalanabis, D., Ashraf, H., Unicomb, L., Eeckels, R., and Tzipori, S. Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a double-blind, controlled clinical trial. Acta Paediatr. 1995;84(9):996-1001
16. Ashraf, H., Mahalanabis, D., Mitra, A. K., Tzipori, S., and Fuchs, G. J. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial. Acta Paediatr. 2001;90(12):1373-1378.
17. Casswall, T. H., Sarker, S. A., Faruque, S. M., Weintraub, A., Albert, M. J., Fuchs, G. J., Alam, N. H., Dahlstrom, A. K., Link, H., Brussow, H., and Hammarstrom, L. Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial. Scand.J.Gastroenterol. 2000;35(7):711-718. 
18. Brinkworth, G. D. and Buckley, J. D. Concentrated bovine colostrum protein supplementation reduces the incidence of self-reported symptoms of upper respiratory tract infection in adult males. Eur.J.Nutr. 2003;42(4):228-232.
19. Plettenberg, A., Stoehr, A., Stellbrink, H. J., Albrecht, H., and Meigel, W. A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea. Clin.Investig. 1993;71(1):42-45.
20. Ebina, T., Ohta, M., Kanamaru, Y., Yamamoto-Osumi, Y., and Baba, K. Passive immunizations of suckling mice and infants with bovine colostrum containing antibodies to human rotavirus. J.Med.Virol. 1992;38(2):117-123. 
21. Greenberg, P. D. and Cello, J. P. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS.
22. J.Acquir.Immune.Defic.Syndr.Hum.Retrovirol. 12-1-1996;13(4):348-354.
23. He, F., Tuomola, E., Arvilommi, H., and Salminen, S. Modulation of human humoral immune response through orally administered bovine colostrum. FEMS Immunol.Med.Microbiol. 2001;31(2):93-96.
24. Crooks, C. V., Wall, C. R., Cross, M. L., and Rutherfurd-Markwick, K. J. The effect of bovine colostrum supplementation on salivary IgA in distance runners. Int J Sport Nutr Exerc.Metab 2006;16(1):47-64.
25. Nord, J., Ma, P., DiJohn, D., Tzipori, S., and Tacket, C. O. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 1990;4(6):581-584
26. Khan, Z., Macdonald, C., Wicks, A. C., Holt, M. P., Floyd, D., Ghosh, S., Wright, N. A., and Playford, R. J. Use of the 'nutriceutical', bovine colostrum, for the treatment of distal colitis: results from an initial study. Aliment.Pharmacol.Ther. 2002;16(11):1917-1922.
27. Huppertz, H. I., Rutkowski, S., Busch, D. H., Eisebit, R., Lissner, R., and Karch, H. Bovine colostrum ameliorates diarrhea in infection with diarrheagenic Escherichia coli, shiga toxin-producing E. Coli, and E. coli expressing intimin and hemolysin. J.Pediatr.Gastroenterol.Nutr. 1999;29(4):452-456
28. Ylitalo, S., Uhari, M., Rasi, S., Pudas, J., and Leppaluoto, J. Rotaviral antibodies in the treatment of acute rotaviral gastroenteritis. Acta Paediatr. 1998;87(3):264-267.
29. Davidson, G. P., Whyte, P. B., Daniels, E., Franklin, K., Nunan, H., McCloud, P. I., Moore, A. G., and Moore, D. J. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet 9-23-1989;2(8665):709-712.
30. Stephan, W., Dichtelmuller, H., and Lissner, R. Antibodies from colostrum in oral immunotherapy. J Clin Chem Clin Biochem 1990;28(1):19-23.
31. Aniansson, G., Andersson, B., Lindstedt, R., and Svanborg, C. Anti-adhesive activity of human casein against Streptococcus pneumoniae and Haemophilus influenzae. Microb.Pathog. 1990;8(5):315-323.
32. Bitzan, M. M., Gold, B. D., Philpott, D. J., Huesca, M., Sherman, P. M., Karch, H., Lissner, R., Lingwood, C. A., and Karmali, M. A. Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum. J.Infect.Dis. 1998;177(4):955-961. Casswall, T. H., Nilsson, H. O., Bjorck, L., Sjostedt, S., Xu, L., Nord, C. K., Boren, T., Wadstrom, T., and Hammarstrom, L. Bovine anti-Helicobacter pylori antibodies for oral immunotherapy. Scand J Gastroenterol 2002;37(12):1380-1385.
33. Flanigan, T., Marshall, R., Redman, D., Kaetzel, C., and Ungar, B. In vitro screening of therapeutic agents against Cryptosporidium: hyperimmune cow colostrum is highly inhibitory. J Protozool. 1991;38(6):225S-227S
34. Griffiths, E. and Humphreys, J. Bacteriostatic effect of human milk and bovine colostrum on Escherichia coli: importance of bicarbonate. Infect.Immun. 1977;15(2):396-401.
35. Korhonen, H., Marnila, P., and Gill, H. S. Milk immunoglobulins and complement factors. Br J Nutr 2000;84 Suppl 1:S75-S80.
36. Naaber, P., Lehto, E., Salminen, S., and Mikelsaar, M. Inhibition of adhesion of Clostridium difficile to Caco-2 cells. FEMS Immunol Med Microbiol. 1996;14(4):205-209.
37. Okabe, T. Protective effects of antibody against intestinal invasion by Escherichia coli. Microbiol.Immunol 1983;27(4):303-310. 
38. Ouwehand, A. C., Conway, P. L., and Salminen, S. J. Inhibition of S-fimbria-mediated adhesion to human ileostomy glycoproteins by a protein isolated from bovine colostrum. Infect.Immun. 1995;63(12):4917-4920
39. Wognum, A. W., Sol, C. J., van der, Noordaa J., van Steenis, G., and Osterhaus, A. D. Isolation and characterization of a papovavirus from cynomolgus macaque kidney cells. Virology 4-15-1984;134(1):254-257.
40. Pacyna, J., Siwek, K., Terry, S. J., Roberton, E. S., Johnson, R. B., and Davidson, G. P. Survival of rotavirus antibody activity derived from bovine colostrum after passage through the human gastrointestinal tract. J.Pediatr.Gastroenterol.Nutr. 2001;32(2):162-167
41. Loimaranta, V., Nuutila, J., Marnila, P., Tenovuo, J., Korhonen, H., and Lilius, E. M. Colostral proteins from cows immunised with Streptococcus mutans/S. sobrinus support the phagocytosis and killing of mutans streptococci by human leucocytes. J Med Microbiol. 1999;48(10):917-926.
42. Sambasivarao, D., Hooton, J., Dost, A., and Paetkau, V. A novel immunosuppressive factor in bovine colostrum blocks activation of the interleukin 2 gene enhancer at the NFAT site. Biochem.Cell Biol. 1996;74(4):585-593.
43. Slukvin, I. I., Pylypenko, V. V., Filchenkov, A. A., and Chernyshov, V. P. [Effect of human colostrum and its fraction on functional activity of B-lymphocytes]. Fiziol.Zh. 1993;39(4):57-62.
44. Penland, J.G., Lukaski, H.C., Gray, J.S. Zinc fortification and cognitive and psychosocial function in young adolescents. Federation of American Societies for Experimental Biology Journal. 17:A1087..
45. Bhatnagar S, Taneja S. Zinc and cognitive development. Br J Nutr. 2001 May;85 Suppl 2:S139-45.
46. Tubek S Role of zinc in regulation of arterial blood pressure and in the etiopathogenesis of arterial hypertension. Biol Trace Elem Res. 2007 Summer;117(1-3):39-51. .
47. Dey Sarkar P, et al. Study of oxidative stress and trace element levels in patients with alcoholic and non-alcoholic coronary artery disease. Indian J Physiol Pharmacol. 2007 Apr-Jun;51(2):141-6.
48. Block G et al. Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study. Nutr J. 2007 Oct 24;6:30.
49. Kazemi-Bajestani SM, et al. Serum copper and zinc concentrations are lower in Iranian patients with angiographically defined coronary artery disease than in subjects with a normal angiogram. J Trace Elem Med Biol. 2007;21(1):22-8.
50. Age-Related Eye Disease Study Research Group. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8. Archives of Ophthalmology. 2001 October;119:1417-1436
51. Mochizuki K, et al. Improvement of scotopic electroretinograms and night blindness with recovery of serum zinc levels. Jpn J Ophthalmol. 2006 Nov-Dec;50(6):532-6. 
52. Sazawal S, et al. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: A double-blind, controlled trial. Pediatrics (1998) 102(1):1-5
53. Prasad AS, et al. Antioxidant effect of zinc in humans. Free Radic Biol Med. 2004 Oct 15;37(8):1182-90.
54. Duchateau J, et al. Influence of oral zinc supplementation on the lymphocyte response to mitogens of normal subjects. Am J Clin Nutr. 1981 Jan;34(1):88-93.
55. Chaudhary U, Nagpal RC, Malik AK, et al. Comparative evaluation of antimicrobial activity of polyvinylpyrrolidone (PVP)-iodine versus topical antibiotics in cataract surgery. J Indian Med Assoc 1998;96(7):202-204.
56. Hollowell JG, Staehling NW, Hannon WH, et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab 1998;83(10):3401-3408.
57. Kahaly G, Dienes HP, Beyer J, et al. Randomized, double blind, placebo-controlled trial of low dose iodide in endemic goiter. J Clin Endocrinol Metab 1997;82(12):4049-4053.
58. Liesenkotter KP, Gopel W, Bogner U, et al. Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur J Endocrinol 1996;134(4):443-448.
59. Richter R, Below H, Kadow I, et al. Effect of topical 1.25% povidone-iodine eyedrops used for prophylaxis of ophthalmia neonatorum on renal iodine excretion and thyroid-stimulating hormone level. J Pediatr. 2006 Mar;148(3):401-3.
60. Zimmermann MB, Connolly K, Bozo M, et al. Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: a randomized, controlled, double-blind study. Am J Clin Nutr. 2006 Jan;83(1):108-14.
61. Anon. From the Centers for Disease Control and Prevention. Lactic acidosis traced to thiamine deficiency related to nationwide shortage of multivitamins for total parenteral nutrition--United States, 1997. JAMA 1997;278(2):109, 111.
62. Abbas ZG, Swai AB. Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy. East Afr Med J 1997;74(12):803-808.
63. Benton D, Fordy J, Haller J. The impact of long-term vitamin supplementation on cognitive functioning. Psychopharmacology (Berl) 1995;117(3):298-305.
64. Cook CC, Hallwood PM, Thomson AD. B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol 1998;33(4):317-336.
65. Hamadani M, Awan F. Role of thiamine in managing ifosfamide-induced encephalopathy. J Oncol Pharm Pract. 2006 Dec;12(4):237-9.
66. Nolan KA, Black RS, Sheu KF, et al. A trial of thiamine in Alzheimer's disease. Arch Neurol 1991;48(1):81-83.
67. Ranganathan LN, Ramaratnam S. Vitamins for epilepsy. Cochrane Database Syst Rev 2005;(2):CD004304. 
68. Yates AA, Schlicker SA, Suitor CW. Dietary Reference Intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J Am Diet Assoc 1998;98(6):699-706.
69. Angkatavanich J, Suthutvoravut U, Panijpan B, et al. Effects of multivitamin supplementation for improvement of thiamin, riboflavin, and retinol nutrition in pediatric patients. J Med Assoc Thai 1993;76 Suppl 2:138-145. 
70. Breen C, Crowe A, Roelfsema HJ, et al. High-dose riboflavin for prophylaxis of migraine. Can Fam Physician 2003;49:1291-1293.
71. Okuda J, Horiguchi N. Nutritional and ariboflavinosis-curing effects of riboflavin-5'-monobutyrate and monopalmitate. Chem Pharm Bull (Tokyo) 1980;28(1):8-13. 
72. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998;50(2):466-470. 
73. Yurdakok M, Erdem G, Tekinalp G. Riboflavin in the treatment of neonatal hyperbilirubinemia. Turk J Pediatr 1988;30(3):159-161.
74. Clarke, R., et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol. 55(11):1449-1455.
75. Corrada MM, et al. Reduced risk of Alzheimer’s disease with high folate intake: The Baltimore Longitudinal Study of Aging. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, July 2005 (Vol. 1, Issue 1, Pages 11-18. 
76. Malaguarnera M, et al. Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease. Clin Chem Lab Med. 42(9):1032-1035.
77. Ravaglia G, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 82(3):636-643.
78. Murakami K, et al. Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults. Nutrition. 2008 Feb;24(2):140-7.
79. Bryan J, Calvaresi E. Associations between dietary intake of folate and vitamins B-12 and B-6 and self-reported cognitive function and psychological well-being in Australian men and women in midlife.
80. Andres E, Kurtz JE, Perrin AE, et al. Oral cobalamin therapy for the treatment of patients with food-cobalamin malabsorption. Am J Med 2001;111:126-9.
81. Booth GL, Wang EE. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. CMAJ 2000;163:21-9.
82. Erol I, Alehan F, Gümüs A. West syndrome in an infant with vitamin B12 deficiency in the absence of macrocytic anaemia. Dev Med Child Neurol 2007 Oct;49(10):774-6.
83. Seal EC, Metz J, Flicker L, et al. A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. J Am Geriatr Soc 2002;50:146-51.
84. Suzuki DM, Alagiakrishnan K, Masaki KH, et al. Patient acceptance of intranasal cobalamin gel for vitamin B12 replacement therapy. Hawaii Med J 2006 Nov;65(11):311-4. 
85. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004;291:565-75. 
86. Yajnik CS, Lubree HG, Thuse NV, et al. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India. Asia Pac J Clin Nutr 2007;16(1):103-9.
87. Martindale: The Complete Drug Reference © 2005 The Pharmaceutical Press.